Introduction: Liver cirrhosis is a major public health problem in sub-Saharan Africa, where it is often diagnosed at an advanced stage and associated with high mortality. This study aimed to identify the factors associated with death in patients with liver cirrhosis at the Tengandogo University Hospital (CHUT). Materials and Methods: This was an analytical cross-sectional study conducted over a period of ten and a half years at CHUT in Ouagadougou. We collected the medical records of patients with liver cirrhosis. Sociodemographic and diagnostic data were collected. A univariate and then a multivariate logistic regression analysis was performed to identify factors associated with death. Authorization from the general management of CHUT was obtained, and patient confidentiality was maintained. Results: The hospital mortality rate was 38.5% (79/205). The majority of patients were male (76.1%) and viral hepatitis B was the main etiology (59.4%). The majority of patients were classified as Child-Pugh B or C (92.2%). The most common complications were ascites (78.5%), cancer (48.3%), hepatic encephalopathy (21.5%), and associated infections (15.1%). In multivariate analysis, hepatic encephalopathy, infections, and the presence of cancer were independently associated with death, while age, sex, etiology, and Child-Pugh score were not independent predictive factors. Conclusion: Mortality among hospitalized cirrhotic patients remains high and is mainly related to cirrhosis-related complications, reflecting late diagnosis. Strengthening HBV screening, early follow-up of patients, and optimal management of complications are essential to improve prognosis.
References
[1]
Friedman, S.L. (2003) Liver Fibrosis—From Bench to Bedside. Journal of Hepatology, 38, 38-53. https://doi.org/10.1016/s0168-8278(02)00429-4
[2]
Asrani, S.K., Devarbhavi, H., Eaton, J. and Kamath, P.S. (2019) Burden of Liver Diseases in the World. Journal of Hepatology, 70, 151-171. https://doi.org/10.1016/j.jhep.2018.09.014
[3]
Sepanlou, S.G., Safiri, S., Bisignano, C., Ikuta, K.S., Merat, S., Saberifiroozi, M., et al. (2020) The Global, Regional, and National Burden of Cirrhosis by Cause in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 5, 245-266. https://doi.org/10.1016/s2468-1253(19)30349-8
[4]
Kramvis, A. and Kew, M.C. (2007) Epidemiology of Hepatitis B Virus in Africa, Its Genotypes and Clinical Associations of Genotypes. Hepatology Research, 37, S9-S19. https://doi.org/10.1111/j.1872-034x.2007.00098.x
[5]
L’OMS tire la sonnette d’alarme sur l’hépatite virale qui tue 3 500 personnes chaque jour. https://www.who.int/fr/news/item/09-04-2024-who-sounds-alarm-on-viral-hepatitis-infections-claiming-3500-lives-each-day
[6]
Agbozo, W.K., Dzudzor, B., Nyarko, E.N., et al. (2022) Sociodemographic and Medical Characteristics of Liver Cirrhosis Deaths in a Ghana-Ian Tertiary Hospital. GhanaMedicalJournal, 56, 259-267. https://doi.org/10.4314/gmj.v56i4.4
[7]
Sehonou, J., Kodjoh, N., Sake, K., et al. (2010) Liver Cirrhosis in Cotonou, Republic of Benin: Clinical Aspects and Factors Related to Death. Médecine tropicale: Revue du Corps de santé colonial, 70, 375-378.
[8]
Somé, E.N., Guingané, N.A., Lompo, T.I., et al. (2021) Cirrhose du foie: Aspects épidémiologiques et diagnostiques au centre hospitalier universitaire Yalgado Ouédraogo. Revue Africaine des Sciences Sociales et de la Santé Publique, 3, 53-64.
[9]
Huang, D.Q., Terrault, N.A., Tacke, F., Gluud, L.L., Arrese, M., Bugianesi, E., et al. (2023) Global Epidemiology of Cirrhosis—Aetiology, Trends and Predictions. NatureReviewsGastroenterology&Hepatology, 20, 388-398. https://doi.org/10.1038/s41575-023-00759-2
[10]
Wu, X.N., Xue, F., Zhang, N., et al. (2024) Global Burden of Liver Cirrhosis and Other Chronic Liver Diseases Caused by Specific Etiologies from 1990 to 2019. BMCPublicHealth, 24, Article No. 363. https://doi.org/10.1186/s12889-024-17948-6
[11]
Tham, E.K.J., Tan, D.J.H., Danpanichkul, P., Ng, C.H., Syn, N., Koh, B., et al. (2025) The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. Liver International, 45, e70001. https://doi.org/10.1111/liv.70001
[12]
Reverter, E., Tandon, P., Augustin, S., Turon, F., Casu, S., Bastiampillai, R., et al. (2014) A Meld-Based Model to Determine Risk of Mortality among Patients with Acute Variceal Bleeding. Gastroenterology, 146, 412-419.e3. https://doi.org/10.1053/j.gastro.2013.10.018
[13]
Moon, A.M., Singal, A.G. and Tapper, E.B. (2020) Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clinical Gastroenterology and Hepatology, 18, 2650-2666. https://doi.org/10.1016/j.cgh.2019.07.060
[14]
Global Hepatitis Report 2017. https://www.who.int/publications/i/item/9789241565455
[15]
Tapper, E.B. and Parikh, N.D. (2018) Mortality Due to Cirrhosis and Liver Cancer in the United States, 1999-2016: Observational Study. British Medical Journal, 362, k2817. https://doi.org/10.1136/bmj.k2817
[16]
Bajaj, J.S., Kamath, P.S. and Reddy, K.R. (2021) The Evolving Challenge of Infections in Cirrhosis. New England Journal of Medicine, 384, 2317-2330. https://doi.org/10.1056/nejmra2021808
[17]
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., et al. (2025) EASL Clinical Practice Guidelines on the Management of Hepatocellular Carcinoma. JournalofHepatology, 82, 315-374. https://doi.org/10.1016/j.jhep.2024.08.028
[18]
Piano, S., Tonon, M. and Angeli, P. (2021) Changes in the Epidemiology and Management of Bacterial Infections in Cirrhosis. ClinicalandMolecularHepatology, 27, 437-445. https://doi.org/10.3350/cmh.2020.0329